DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.70 (2024) >

このアイテムの引用には次の識別子を使用してください: http://ir.fmu.ac.jp/dspace/handle/123456789/2211

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_70_p35.pdf1.04 MBAdobe PDFダウンロード
タイトル: Evaluation and treatment of constipation in pregnancy: Examination using the Japanese version of the constipation evaluation scale
著者: Ishibashi, Makiho
Hashimoto, Fumie
Kouchi, Yoshihiro
Imaizumi, Karin
Ito, Fumihiro
Yasuda, Shun
誌名/書名: Fukushima Journal of Medical Science
巻: 70
号: 1
開始ページ: 35
終了ページ: 47
発行日: 2024年
抄録: Objectives: No study has examined the effects of new constipation treatment drugs released in recent years in pregnant women. This prospective cohort study aimed to examine and compare the perinatal prognosis, efficacy rate, and safety of drugs frequently used to treat constipation. Methods: The study included 211 perinatally managed individuals who answered a self-administered questionnaire during the second trimester and after delivery. The Japanese version of the constipation evaluation scale (Constipation Assessment Scale [CAS] long-term [LT] version) was used for the subjective evaluation of defecation status. Results: Participants aware of constipation had significantly higher CAS scores than those who were unaware. Some participants with a CAS score of 5 points (treatment range) had no subjective symptoms of constipation, whereas some participants with a CAS score of ≤ 5 points were aware of constipation. Regarding the time of onset, 60% of those who had constipation before pregnancy had a high rate of constipation during pregnancy and after delivery. No significant difference was noted in conventional magnesium oxide and polyethylene glycol, a relatively new daily treatment drug, in perinatal prognosis or side effects. Conclusions: Polyethylene glycol preparations alleviate constipation without inducing diarrhea, making them an appropriate therapeutic option for pregnant women.
出版者: The Fukushima Society of Medical Science
出版者(異表記): 福島医学会
本文の言語: eng
このページのURI: http://ir.fmu.ac.jp/dspace/handle/123456789/2211
本文URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/2211/1/FksmJMedSci_70_p35.pdf
ISSN: 0016-2590
2185-4610
DOI: 10.5387/fms.2023-25
PubMed番号: 38267029
関連ページ: https://doi.org/10.5387/fms.2023-25
権利情報: © 2024 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
権利情報: https://creativecommons.org/licenses/by-nc-sa/4.0/
出現コレクション:Vol.70 (2024)

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_70_p35.pdf1.04 MBAdobe PDFダウンロード

このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。

 

DSpace Software Copyright © 2002-2006 MIT and Hewlett-Packard